In Minnesota, lawmakers are considering SF 2767, a bill that would make several modifications to the state’s medical marijuana laws. Under the proposed legislation, patients with inflammatory bowel disease would be able to enroll in the state medical marijuana program.
Current law allows for those suffering from Crohn’s Disease to qualify, but has no provisions for those suffering from other bowel diseases. It is the hope of bill sponsors that increased patient enrollment can lead to lower costs for medical marijuana.
Another important change in the bill would allow pharmacists to consult with medical marijuana patients via teleconference. Under existing law, pharmacists must physically dispense medical marijuana by hand.
According to the Star Tribune, SF 2767 passed out of committee by a voice vote on April 1, 2016, and is expected to be taken up by the House Health and Human Services Reform Committee within the week.